Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treprostinil PatchPump - United Therapeutics

Next Previous
Drug Profile

Treprostinil PatchPump - United Therapeutics

Alternative Names: Treprostinil sodium - United Therapeutics; Trevyent

Latest Information Update: 13 Mar 2023

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator SteadyMed Therapeutics
  • Class Acetic acids; Antifibrotics; Antihypertensives; Cyclopentanes; Naphthalenes; Prostaglandins; Skin disorder therapies; Small molecules; Vasodilators
  • Mechanism of Action Epoprostenol receptor agonists; Platelet aggregation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Pulmonary hypertension
  • New Molecular Entity No

Highest Development Phases

  • Discontinued Pulmonary arterial hypertension; Pulmonary hypertension

Most Recent Events

  • 13 Mar 2023 Discontinued - Clinical-Phase-Unknown for Pulmonary hypertension in Canada, Middle East, Europe (SC) prior to March 2023
  • 13 Mar 2023 Discontinued - Preregistration for Pulmonary arterial hypertension in USA (SC) prior to March 2023
  • 10 Feb 2021 Cipher Pharmaceuticals and Verity Pharmaceuticals enter into co-promotion agreement for treprostinil patchPump

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top